Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01254578
What this trial is testing

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+39 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)WithdrawnNCT04392128
What this trial is testing

Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)

Who this might be right for
COVID19Hematologic Malignancy
Institut de cancérologie Strasbourg Europe
Testing effectiveness (Phase 2)Study completedNCT00290992
What this trial is testing

Rasburicase for Hyperuricemia

Who this might be right for
Nutritional and Metabolic Diseases
Sanofi 30
Large-scale testing (Phase 3)Study completedNCT03837171
What this trial is testing

TRANSfusion in Patients With Onco-hematological Malignancies ResusciTated From Septic Shock

Who this might be right for
Septic ShockAnemiaCancer
Assistance Publique - Hôpitaux de Paris 192
Not applicableLooking for participantsNCT07189117
What this trial is testing

Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies

Who this might be right for
Hematologic Malignancy
University Hospital, Basel, Switzerland 350
Testing effectiveness (Phase 2)Study completedNCT01086735
What this trial is testing

Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematological Malignancy
Assistance Publique - Hôpitaux de Paris 11
Not applicableEnded earlyNCT04093622
What this trial is testing

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

Who this might be right for
Hematological Malignancy
Fate Therapeutics 2
Not applicableLooking for participantsNCT05009537
What this trial is testing

Optical Genome Mapping in Hematological Malignancies

Who this might be right for
MDSALLOther Hematologic Malignant Neoplasms
University Hospital, Brest 200
Very early researchUnknownNCT04700319
What this trial is testing

CAR-T CD19/CD20 for Patients With Advanced CD19/CD20+ B Cell Line Recurrent or Refractory Hematological Malignancies

Who this might be right for
CAR
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT02265731
What this trial is testing

Study Evaluating Venetoclax in Subjects With Hematological Malignancies

Who this might be right for
Non-Hodgkin Lymphoma (NHL)Multiple Myeloma (MM)Chronic Lymphocytic Leukemia (CLL)+2 more
AbbVie 38
Early research (Phase 1)Study completedNCT00001748
What this trial is testing

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

Who this might be right for
Graft vs Host DiseaseHematologic NeoplasmsLymphoma+2 more
National Heart, Lung, and Blood Institute (NHLBI) 35
Testing effectiveness (Phase 2)Study completedNCT02193958
What this trial is testing

Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
AMLCMMLMDS
Fujifilm Pharmaceuticals U.S.A., Inc. 55
Not applicableLooking for participantsNCT05379738
What this trial is testing

Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological Malignancy

Who this might be right for
Haematological Malignancy
Centre Hospitalier Universitaire de Nice 75
Early research (Phase 1)Ended earlyNCT03051035
What this trial is testing

First-in-Human Study of KO-947 in Non-Hematological Malignancies

Who this might be right for
Advanced Malignant Neoplasm
Kura Oncology, Inc. 61
Not applicableNot Yet RecruitingNCT07108023
What this trial is testing

Hematological Disorders in EHPVO Patients

Who this might be right for
Extrahepatic Portal Vein Obstruction (EHPVO)ThrombophiliaMyeloproliferative Neoplasms (MPN)+5 more
Rahab Nady 115
Early research (Phase 1)Study completedNCT01551524
What this trial is testing

Phase I Study of mPEG-R-Crisantaspase Given IV

Who this might be right for
Hematologic Malignancies
Jazz Pharmaceuticals 36
Not applicableStudy completedNCT03896880
What this trial is testing

Detection of Bloodstream Pathogens in Hematological Malignancies

Who this might be right for
Bloodstream Infection
Assiut University 139
Early research (Phase 1)Study completedNCT00506402
What this trial is testing

MKC-1 in Patients With Refractory Hematologic Malignancies

Who this might be right for
Hematological MalignanciesMyelodysplasiaAgnogenic Myeloid Metaplasia
CASI pharmaceuticals, Inc. 30
Not applicableStudy completedNCT04755465
What this trial is testing

Effects of NMES and Exercise in Hematological Cancer

Who this might be right for
Hematologic MalignancyMuscle Weakness
Acibadem University 31
Testing effectiveness (Phase 2)Study completedNCT02210065
What this trial is testing

Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 6
Next Page